Bluebird Bio, Inc. (BLUE)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

37

0

3

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Mar-24 5:40 PM View:	04-Mar-24 Sale ($9.31K)	Obenshain Andrew President and CEO Director		Bluebird Bio, Inc. - BLUE	(4%) 291.13K to 280.0K	0	0	--	--	Show Txns Hide Txns

04-Jun-24 4:22 PM View:	03-Jun-24 Sale ($3.73K)	Klima Thomas J See Remarks		Bluebird Bio, Inc. - BLUE	(8%) 132.13K to 121.01K	0	0	--	--	Show Txns Hide Txns

02-Oct-24 4:06 PM View:	30-Sep-24 Grant 0	Colvin Richard A Chief Medical Officer		Bluebird Bio, Inc. - BLUE	34% 125.73K to 168.37K	0	0	--	--	Show Txns Hide Txns

08-Dec-23 4:42 PM View:	06-Dec-23 Sale ($20.44K)	Krawtschuk Christopher Chief Financial Officer		Bluebird Bio, Inc. - BLUE	(9%) 50.0K to 45.47K	0	0	--	--	Show Txns Hide Txns

02-Oct-24 4:06 PM View:	30-Sep-24 Grant 0	Vittiglio Joseph Chief Business & Legal Officer		Bluebird Bio, Inc. - BLUE	90% 50.0K to 94.78K	0	0	--	--	Show Txns Hide Txns

02-Oct-24 4:06 PM View:	30-Sep-24 Grant 0	Sterling O. James Chief Financial Officer		Bluebird Bio, Inc. - BLUE	100% 0 to 100.0K	0	0	--	--	Show Txns Hide Txns